"Todays approval is another demonstration of what the FDA can accomplish when we try bold new things." The higher-dose GLP-1 is indicated to "reduce excess body weight and maintain weight reduction long-term in adults with obesity, or overweight with at least one weight-related condition," per the FDA's statement
Both comparisons reached statistical significance for superiority
BMC Rheumatol
If any unusual symptoms appear whilst using them then consult a doctor straight away to ensure that you are safe and healthy
The most well-known names are: Semaglutide the active ingredient in Ozempic (diabetes) and Wegovy (weight loss) Tirzepatide the active ingredient in Mounjaro (diabetes) and Zepbound (weight loss), which works on both GLP-1 and GIP receptors Clinical trials have shown average weight loss of 1522% of body weight with these medications when combined with lifestyle changes numbers that far exceed what most people can achieve through diet and exercise alone
When comparing LifeMD to PlexusDx, consider your clinical priorities: rapid brand-name access (LifeMD), lower-cost compounded entry with optional genetic insight (PlexusDx), or a hybrid approach consulting both telehealth and precision-testing resources